Tuesday, April 14, 2009

8. Teams

Based on initial interest, we’re likely to see a large number of entrants to the Healthcare X PRIZE, but most will not be comprehensive enough to be a legitimate competitor on their own. Given the large number of point solutions and a dearth of comprehensive approaches in the health innovation space, we plan to create an ecosystem where teams/partners/sponsors/ financiers can come together and form teams offering more comprehensive solutions. The initial prize timeline of 18 months from competition launch to finalist selection may need to be adjusted should early entries require significant time to build relationships and organize themselves into teams that can deliver a comprehensive solution.

Upon Entry, a team will need to show an early concept and have sufficient resources to pay an initial registration fee. The Concept stage has a more rigorous hurdle; teams will need to be able to demonstrate the effectiveness of their solution in a predictive model with 10,000 sample records. Only those who can successfully model a 50% improvement in health value will move to the next round. As mentioned above, we believe that many of the teams in the Entry and Concept stages will find their solution insufficient to win the prize…we need to help them determine their limitations quickly and help them find partners that will allow them to move forward in the competition. The Pilot phase will show real world proof points for several key assumptions in the model demonstrated at Concept. The Pilot phase will also require an alpha version of the products and services of the teams to be developed. Five Finalists will be selected from those who have successfully completed the Pilot requirements and they will then be matched into a test group for the real world competition during a 3 year trial.

Teams are likely to bring a number of capabilities together into their solution. Areas of innovation we expect to see include:
  • Financing/ Payment
  • Behavior modification
  • Comparative effectiveness
  • Personalized decision support
  • Tracking/ feedback
  • Coordination of care
  • eHealth tools and technology
  • Convenience
  • Care Experience
We expect teams to demonstrate the impact of their solutions in their test populations during the 3 year trial. Test populations are intended to include many different types of individuals to reflect the general population. All efforts will be made to create actuarially equivalent and representative populations in our test groups. In creating equivalent test populations, we will need to balance inclusiveness of a general population with the need to cost-effectively capture sufficient data to show the required changes during the 3 year trial window. We will need to balance the number of people in the trial populations, the mix across health status, and rules/boundaries in dealing with health conditions that may have significant ethical considerations.
blog comments powered by Disqus